The firm reported earnings per share of $0.14 for the fourth quarter of 2025, exceeding the anticipated $0.12 per share. This marks a growth from $0.06 per share a year ago.
SBC Medical Group Holding recorded revenue of $39.57 million for the fourth quarter of 2025, which was below the projected $45.44 million and represented a decrease from $44.42 million a year earlier.
EBITDA margin for the fourth quarter of 2025 was 34 percent, reflecting a decrease of 12 percentage points from the previous year.
rnTotal revenues for the full year 2025 were $174 million, indicating a 15 percent decline from the prior year. Earnings per share for the full year were $0.50. The EBITDA margin for the full year was 40 percent, a decrease of 3 percentage points from the previous year.
Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical, commented: “Our full-year 2025 results reflect a business in transition. Revenue declined 15 percent to $174 million, primarily due to two structural changes.”
